Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  cardiovascular complications
Country:  U.S.A.
Trial Type:  Supportive care
Results 1-14 of 14 for your search:
Start Over
Atorvastatin Calcium in Preventing Cardiovascular Complications in Patients with Newly Diagnosed Stage I-III Breast Cancer or Stage I-IV Lymphoma Undergoing Anthracycline-Based Chemotherapy
Status: Active
Phase: Phase III, Phase II
Type: Supportive care
Age: 30 to 80
Trial IDs: 98213, NCI-2013-01760, 00024197, CCCWFU 98213, WF 98213, WFU 98213, NCT01988571
Bortezomib or Carfilzomib with Lenalidomide and Dexamethasone in Treating Patients with Newly Diagnosed Multiple Myeloma
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: E1A11, NCI-2012-02608, ECOG-E1A11, NCT01863550
Simvastatin in Reducing Cardiac Toxicity in Patients with Stage I-III Breast Cancer Receiving Chemotherapy
Status: Active
Phase: Phase II
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: J13160, NCI-2014-01435, CIR00005458, JHMIRB 6, SKCCC J13160, NCT02096588
Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention, Supportive care
Age: Any age
Trial IDs: ALTE1621, NCI-2016-00232, COG-ALTE1621, NCT02717507
Genistein in Preventing Cardiometabolic Dysfunction in Patients with Prostate Cancer Undergoing Androgen Deprivation Therapy
Status: Active
Phase: Phase II
Type: Prevention, Supportive care
Age: 18 and over
Trial IDs: EU3129-15, NCI-2016-00400, IRB00086186, NCT02766478
Weight-Based versus Standard Dose Enoxaparin in Preventing Blood Clots in High-Risk Hospitalized Patients with Cancer
Status: Active
Phase: Phase II
Type: Prevention, Supportive care
Age: 18 to 70
Trial IDs: 15-547, NCI-2016-00891, NCT02706249
Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiopulmonary Bypass
Status: Active
Phase: Phase II
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: GTI1307, NCI-2017-01094, NCT02037555
Exercise Therapy and Quality of Life in Postmenopausal Early Breast Cancer Survivors Receiving Aromatase Inhibitor Therapy
Status: Active
Phase: No phase specified
Type: Educational/Counseling/Training, Supportive care
Age: Not specified
Trial IDs: 1B-12-1, NCI-2010-01265, HS-12-00141, NCT01140282
MRI in Detecting Heart Damage in Patients with Cancer Receiving Chemotherapy
Status: Active
Phase: No phase specified
Type: Diagnostic, Supportive care
Age: 22 and over
Trial IDs: CCCWFU 99112, NCI-2012-01613, NCT01719562
Cardiac Magnetic Resonance Imaging in Detecting Cardiac Toxicity Caused by Doxorubicin Hydrochloride-Based Chemotherapy in Patients With Lymphoma
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic, Supportive care
Age: 18 and over
Trial IDs: 11-443, NCI-2012-00537, NCT02055040
Cardiorespiratory Function in Patients with Metastatic Hormone-Resistant Prostate Cancer Undergoing Treatment with Sipuleucel-T, Abiraterone Acetate, or Enzalutamide
Status: Active
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: Pro00058229, NCI-2015-00581, NCT02353715
Statin Risk Communication Tool in Increasing Statin Use in Cancer Survivors
Status: Active
Phase: No phase specified
Type: Supportive care
Age: 25 and over
Trial IDs: 16-1128, NCI-2016-01636, NCT02895880
Physical Activity and Nutrition Counseling in Improving Heart and Lung Health in Patients with Stage I-II Endometrial Cancer
Status: Active
Phase: No phase specified
Type: Supportive care
Age: 19 and over
Trial IDs: Pro00074542, NCI-2016-01968, NCT02987881
Staying Strong and Healthy
Status: Active
Phase: No phase specified
Type: Supportive care
Age: 21 and over
Trial IDs: STUDY00004205, NCI-2017-00337, NCT02969577
Start Over